Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2012 Publisher: MercuryPharm Ltd 4045, Kingswood Road City West Business Park Co Dublin Ireland
Doxapram acts as a ventilatory stimulant and is specifically indicated in the following situations:
Acute Respiratory failure:
Following anaesthesia:
Dopram infusion is recommended for intravenous use only.
For the treatment of respiratory failure recommended dosage is 1.5 to 4 mg per minute depending on the condition and response of the patient. Administer concurrently with oxygen. Whenever possible the condition of the patient should be monitored by frequent measurement of blood gas tensions.
The following dosage regimen has been shown to result in the rapid production of a steady state plasma concentration of doxapram:
0-15 mins | 4.0 mg/min |
15-30 mins | 3.0 mg/min |
30-60 mins | 2.0 mg/min |
60 mins onwards | 1.5 mg/min |
Following anaesthesia recommended dosage is 2-3 mg per minute, and appropriate adjustments to the administration rate should be made according to the response of the patient.
Dopram is not recommended for use in children due to insufficient data on safety and efficacy.
Overdosage may result in hypertension, tachycardia and other arrhythmias; skeletal muscle hyperactivity including enhanced deep tendon reflexes, and dyspnoea. Serious symptoms of overdosage may include clonic and generalized seizures. Intravenous diazepam, phenytoin, and short-acting barbiturates, oxygen and resuscitative equipment should be readily available to manage overdoses.
2 years.
Store below 25°C.
Primary container: Viaflex bag in overpouch.
Secondary container: Cardboard carton.
Presentation: each Viaflex bag contains 500 ml.
The VIAFLEX Plus container has an outlet port designed for an administration set with a short single connector. If an administration set with a combined air inlet/fluid path connector has to be used, ensure the air inlet tube is always clamped off.
Cautions:
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.